The severity of valvular heart disease in euthyroid individuals is associated with thyroid hormone levels but not with TSH levels

Background Abnormal thyroid function is a metabolic disorder and can lead to several complications, including cardiovascular diseases. In this study, we aimed to examine the relationship between clinical traits and outcomes and the thyroid hormone level of euthyroid individuals with valvular heart disease (VHD). Method The thyroid function was evaluated in 526 euthyroid VHD patients and 155 healthy control people. As well as clinical indicators were collected and analyzed. Results No difference in TSH levels (p>0.05) was recorded; however, fT3, TT3, and TT4 levels were lower in the euthyroid VHD patients than in healthy control(4.3 vs 4.63; 1.37 vs 1.48; 97.7 vs 102.09, respectively, all p<0.05), while the fT4 level was higher (12.91 vs 12.35, p<0.05). Moreover, all showed a continuous trend with the change of NYHA grade which does not consist of the incidence of euthyroid sick syndrome(ESS). Further analysis showed that for every 10-fold increase in BNP, fT4 increases by 83%, fT3 decreases by 30%, and TT3 decreases by 12% after being adjusted for other influencing factors. Meanwhile, adjusted fT4 was correlated with multiple worse clinical indicators, which were influenced by age. Conclusion Thyroid hormones are widely regulated in VHD patients even with acceptable cardiac function, except for TSH level. And the adjusted fT4 is related to worse clinical indicators and outcomes which are only recorded in patients under 53 years old.

[1]  Marco Piñón,et al.  I Overview , 2020, The Diaries and Letters of Lord Woolton 1940-1945.

[2]  Chun-Yu Chang,et al.  Non-thyroidal illness syndrome and hypothyroidism in ischemic heart disease population: Systematic review and meta-analysis. , 2020, The Journal of clinical endocrinology and metabolism.

[3]  P. Guida,et al.  Thyroid disorders and prognosis in chronic heart failure: a long-term follow-up study. , 2020, Endocrine, metabolic & immune disorders drug targets.

[4]  D. Bauer,et al.  The Impact of Levothyroxine on Cardiac Function in Older Adults with Mild Subclinical Hypothyroidism: a Randomized Clinical Trial. , 2019, The American journal of medicine.

[5]  B. Biondi,et al.  Subclinical Hypothyroidism: A Review. , 2019, JAMA.

[6]  A. Leite-Moreira,et al.  The Role of Thyroid Hormones in Heart Failure , 2019, Cardiovascular Drugs and Therapy.

[7]  D. Jurkovic,et al.  Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception , 2019, The New England journal of medicine.

[8]  P. Shaw,et al.  Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes , 2018, Circulation. Heart failure.

[9]  H. Woodrow,et al.  : A Review of the , 2018 .

[10]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[11]  P. Langhorne,et al.  Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism , 2017, The New England journal of medicine.

[12]  D. Bauer,et al.  Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST) , 2017, BMC Endocrine Disorders.

[13]  O. Franco,et al.  Thyroid Function and Sudden Cardiac DeathClinical Perspective , 2016 .

[14]  Xin Gao,et al.  Thyroid Function, Prevalent Coronary Heart Disease, and Severity of Coronary Atherosclerosis in Patients Undergoing Coronary Angiography , 2015, International journal of endocrinology.

[15]  B. Psaty,et al.  Thyroid function in the euthyroid range and adverse outcomes in older adults. , 2015, The Journal of clinical endocrinology and metabolism.

[16]  P. Hao,et al.  Effects of thyroid dysfunction on the severity of coronary artery lesions and its prognosis. , 2014, Journal of cardiology.

[17]  Daniel B Mark,et al.  Thyroid function in heart failure and impact on mortality. , 2013, JACC. Heart failure.

[18]  B. Biondi,et al.  Subclinical thyroid disease , 2012, The Lancet.

[19]  B. Hoogwerf,et al.  Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. , 2011, Thyroid : official journal of the American Thyroid Association.

[20]  A. Kotanidou,et al.  Thyroid function during critical illness , 2011, Hormones.

[21]  Ian Harvey,et al.  Patients' Self-Assessed Functional Status in Heart Failure by New York Heart Association Class: A Prognostic Predictor of Hospitalizations, Quality of Life and Death , 2010, Journal of cardiac failure.

[22]  I. Klein,et al.  Thyroid disease and the heart. , 2007, Circulation.

[23]  N. Osman,et al.  Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. , 2005, Journal of the American College of Cardiology.

[24]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[25]  A. L'Abbate,et al.  Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease , 2003, Circulation.

[26]  C. Gorman,et al.  Euthyroid sick syndrome: an overview. , 1997, Thyroid : official journal of the American Thyroid Association.

[27]  L. Tavazzi,et al.  Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. , 1996, European heart journal.

[28]  A. Zaman,et al.  Thyroid hormones and cardiovascular disease , 2017, Nature Reviews Cardiology.

[29]  M. Weickert,et al.  Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. , 2017, The New England journal of medicine.

[30]  E. Vittinghoff,et al.  Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. , 2008, Journal of the American College of Cardiology.

[31]  A. L'Abbate,et al.  Low-T 3 Syndrome A Strong Prognostic Predictor of Death in Patients With Heart Disease , 2003 .

[32]  J. Epstein,et al.  A long-term follow-up study , 1997 .

[33]  E. Glaser The randomized clinical trial. , 1972, The New England journal of medicine.